neostigmine has been researched along with Infections in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Infections: Invasion of the host organism by microorganisms or their toxins or by parasites that can cause pathological conditions or diseases.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Argov, Z | 1 |
Abramsky, O | 1 |
Gekht, VM | 1 |
Kuzin, MI | 1 |
Kuralsein, MG | 1 |
Shagal, DI | 1 |
2 other studies available for neostigmine and Infections
Article | Year |
---|---|
[Antibiotic treatment in myasthenia gravis].
Topics: Adolescent; Aged; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Female; Human | 1982 |
[Treatment of severe forms of myasthenia with prednisolone and triamcinolone].
Topics: Adolescent; Adult; Drug Therapy, Combination; Female; Humans; Infections; Male; Middle Aged; Myasthe | 1975 |